EEG functional connectivity as a prognostic biomarker of adaptive function in autistic people

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Many autistic people have challenges with adaptive function, impacting education, employment and independent-living goals. Adaptive function outcomes of autistic people vary considerably, which makes planning for future needs challenging. Here, using a developmentally sensitive approach, we investigated if cortico-cortical functional connectivity - a core neurobiological feature that differs in autism - could predict longitudinal changes in adaptive function in autistic people. Using electroencephalography in 150 autistic and 159 non-autistic participants aged 6-31 years, we investigated if mean degree and network organisation (small-world index) predict longitudinal changes in adaptive function over 19-months. We assessed both metrics for properties desired in prognostic biomarkers: reliability and convergence with biology (polygenic variation). We found that small-world index significantly predicted changes in adaptive function in autistic people across the entire age-range. Predictive performance was best in 15-21-year-olds, where small-world index and mean degree explained 30-33% of additional variance in outcomes, outperforming measures of intelligence and autistic features. In categorising binary (improved versus not-improved) outcomes, the model containing mean degree had an AUC of 0.80 [95% CI: 0.63-0.97] in 15-21-year-olds, while that containing small-world index had an AUC of 0.76 [95% CI: 0.63-0.89] across the 6-31-year age-range. Both metrics demonstrated high test-retest reliability and significant associations with polygenic variation in brain volume. We demonstrate the first evidence that electroencephalography-derived functional connectivity metrics show promise as prognostic biomarkers of adaptive function in autistic people. Potential precision-medicine applications include stratifying participants in clinical trials and identifying those at risk of declining function in clinical settings.

Article activity feed